Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pharmacological Research|March 1, 2016
Targeting metabolic reprogramming as a potential therapeutic strategy in melanomaLorey K Smith, Aparna D Rao, Grant A McArthurJournal of Neuro-Oncology|June 19, 2025
Long-term clinical outcomes of bevacizumab for treatment of stereotactic radiosurgery-induced radiation necrosis in patients with brain metastasesKylie Jung, Sudhir Das Sivadas, Xavier Fitzgerald, et al.Melanoma Research|June 17, 2014
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanomaSamantha E Bowyer, Aparna D Rao, Megan Lyle, et al.Journal for Immunotherapy of Cancer|May 16, 2025
Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanomaRiyaben P Patel, Lydia Rui Jia Lim, Reem Saleh, et al.Cancer Research|February 12, 2022
A Short Isoform of Spermatogenic Enzyme GAPDHS Functions as a Metabolic Switch and Limits Metastasis in MelanomaJennifer G Gill, Samantha N Leef, Vijayashree Ramesh, et al.Science Advances|March 26, 2025
Assessing cancer therapeutic efficacy in vivo using [2H7]glucose deuterium metabolic imagingMario C Chang, Vinay R Malut, Rohit Mahar, et al.Science Advances|August 31, 2022
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumorsPanayotis Pachnis, Zheng Wu, Brandon Faubert, et al.Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.Nature Metabolism|July 30, 2025
Conservation and divergence of metabolic phenotypes between patient tumours and matched xenograftsAparna D Rao, Ling Cai, Marelize Snyman, et al.Nature Communications|June 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanomaAndrea Di Pietro, Lewis Au, Patrick Crock, et al.Pageof 2